<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392674</url>
  </required_header>
  <id_info>
    <org_study_id>NTCS-20200508</org_study_id>
    <nct_id>NCT04392674</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation</brief_title>
  <official_title>Safety and Efficacy of Using the New Tissue Containment System With Hard Pipes Which Can Assemble With Detachable Trocars Seamlessly for Tissue Removal During Laparoscopic Myomectomy Morcellation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jing Liang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China-Japan Friendship Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the safety of performing the new tissue containment system
      during laparoscopic myomectomy morcellation. Pre- and perimenopausal women, aged 18-45
      undergoing laparoscopic myomectomy morcellation
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 20, 2020</start_date>
  <completion_date type="Anticipated">May 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The safety of using the new tissue containment system for contained cutting and extracting tissue during laparoscopic myomectomy morcellation</measure>
    <time_frame>approximately two years</time_frame>
    <description>The safety of using the new tissue containment system for cutting and extracting tissue during laparoscopic myomectomy morcellation will be determined by the rate of leakage
Leakage is defined as &quot;disruption of the device (using dye leak testing) or visible tissue dissemination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The probability of failure during in-bag morcellation procedure</measure>
    <time_frame>approximately two years</time_frame>
    <description>Failure is defined as the operator's inability to successfully insert and extract the device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean procedure time</measure>
    <time_frame>approximately two years</time_frame>
    <description>Mean procedure time will be measured by hour/minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss during operation</measure>
    <time_frame>approximately two years</time_frame>
    <description>Blood loss during operation will be measured by volume (mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>approximately two years</time_frame>
    <description>Post-operative pain will be measured by Visual Analog Score - VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra- or post-operative complications</measure>
    <time_frame>approximately two years</time_frame>
    <description>Intra or post complications rate (e.g. urinary, intestinal or nerve injury)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Surgeon Task Load Index</measure>
    <time_frame>approximately two years</time_frame>
    <description>The Surgeon Task Load Index be measured by designated Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Patients' life quality postoperative</measure>
    <time_frame>approximately two years</time_frame>
    <description>The Patients' life quality postoperative be measured by Questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Gynecologic Surgery</condition>
  <arm_group>
    <arm_group_label>using the new tissue containment system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>using the new tissue containment system during Laparoscopic myomectomy morcellation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the new tissue containment system</intervention_name>
    <description>using the new tissue containment system during Laparoscopic myomectomy morcellation</description>
    <arm_group_label>using the new tissue containment system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre- and Peri-menopausal woman patient age 18-45 years

               -  Women with fibroids and indication for laparoscopic myomectomy.

               -  Normal Pap smear result within one year

               -  MRI ( Magnatic Resonance Imaging ) or other imaging findings indicate the
                  diameter of the largest uterine fibroids is between 4 to 10cm.

               -  The body mass index of the patients is 18.5-27.9kg/m2

               -  Signed informed consent form

        Exclusion Criteria:

          -  • Women with Known or suspected malignancy

               -  patients with severe pelvic adhesion found during the operation

               -  The body mass index of the patient ≥ 28kg/m2

               -  Diameter of a single uterine fibroid＞10cm

               -  patients during pregnancy and lactation

               -  Known blood diseases, bleeding coagulation disease, any part of the active
                  bleeding or bleeding tendency of the constitution of the patient

               -  Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST)
                  ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit

               -  Patients who are known to have participated in any other clinical trial within 3
                  months

               -  Patients who cannot sign informed consent

               -  Patients with acute stage infection of the reproductive system or other sites
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fang Zhao, MD</last_name>
    <phone>861084206115</phone>
    <email>fangzhaow@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yao Wang, PHD</last_name>
    <phone>861084205983</phone>
  </overall_contact_backup>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 14, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>China-Japan Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Jing Liang</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>morcellation</keyword>
  <keyword>myomectomy</keyword>
  <keyword>laparoscopic surgery</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD will to be shared with other researchers after four years</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

